In the current study, we aimed to reveal the role of DSCAM‐AS1 in luminal breast cancer progression and prognosis by utilizing cellular experiments and analyzing a large cohort of luminal breast cancer samples. The gene discussed is DSCAM-AS1; the disease is breast cancer.